US FDA staff raise no concerns about Otsuka, Medtronic blood pressure devices
(Reuters) – The U.S. Food and Drug Administration (FDA) staff reviewers said on Friday they found no safety and effectiveness issues with devices made by Otsuka Holdings and rival Medtronic Plc for use in a blood pressure treatment surgery. The FDA staff’s assessment comes ahead of meetings of two independent expert panels next week, where…